Skip to Main Content

Paper Details

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma.
Cancers (Basel)
22
2020
Author NameAffiliation
Kelly ReganThe Ohio State University College of Medicine
Lianbo YuThe Ohio State University College of Medicine
Philip R O PayneWashington University Institute for Informatics, Washington University in St. Louis School of Medicine
  • 1 - 3

Datasets

Release 1.2